Examining Music Educators' Support for the DEI Backlash
Action Criticism and Theory for Music Education · 01.05.2026 · 25 (3) · 56
DOI: 10.22176/act25.3.56 ↗Kurz gefasst
Fachartikel in der Zeitschrift Action Criticism and Theory for Music Education, online erschienen am 01.05.2026. Verfasst von Karen Salvador.
Abstract (Originalsprache)
Since 2021, legislatures and state-level actors in twenty-five states have enacted laws limiting instruction on race, gender, sexual orientation, and history in PK–12 schools and higher education. These “divisive concepts laws” (DCLs) are part of a broader backlash against diversity, equity, and inclusion (DEI). While some music educators and teacher educators report negative effects on curriculum, students, and professional wellbeing, about 25% support the DEI backlash, claim DCLs are not divisive, or state they are beneficial for students. Using qualitative content analysis, I identified six themes—bullshit asymmetry, [White] rage, DEI orthodoxies, antipolitics, diversity ideology, and anticipatory obedience—that contribute to and/or accompany this support. In this article, I define each and describe relevant discourses among music educators and teacher educators who support the DEI backlash. I conclude by suggesting communication strategies for preserving or advancing culturally sustaining, gender-inclusive, and ability-responsive practices in music and teacher education.
Zitieren
APA
Salvador, K. (2026). Examining Music Educators' Support for the DEI Backlash. Action Criticism and Theory for Music Education, 25(3), 56. https://doi.org/10.22176/act25.3.56
Vancouver
Salvador K. Examining Music Educators' Support for the DEI Backlash. Action Criticism and Theory for Music Education. 2026;25(3):56. doi:10.22176/act25.3.56
BibTeX
@article{Salvador2026,
author = {Salvador, Karen},
title = {Examining Music Educators' Support for the DEI Backlash},
journal = {Action Criticism and Theory for Music Education},
year = {2026},
volume = {25},
number = {3},
pages = {56},
doi = {10.22176/act25.3.56}
}
EUVIMED